# CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors

> **NCT07657585** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 91 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumors

## Interventions

- **BIOLOGICAL:** CIB in vivo CAR-T Lentiviral Injection

## Key facts

- **NCT ID:** NCT07657585
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-05-31
- **Target enrollment:** 91 (ESTIMATED)
- **Last updated:** 2026-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657585, "CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07657585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*